Nick Samedi Associate

New Jersey
T 973.597.2428 | F 973.597.2429

Nick focuses his practice on an array of corporate legal matters with a special emphasis on buy- and sell-side public and private mergers and acquisitions, joint ventures, asset dispositions, and corporate governance matters. Nick’s practice also includes transactions that encompass refinancing, restructuring, securities offerings, and private investments. He represents a wide range of clients–from strategic buyers and sellers to investment funds and private growth-stage technology companies–who have come to rely on his understanding of their financial condition and business objectives. Nick has advised clients in many different industries, including the pharmaceutical, biotechnology, manufacturing, publishing, cosmetics, gaming, and recycling industries.

Nick has a passion for pro bono work and negotiated the merger of several nonprofit entities into Literacy NJ, a nonprofit organization dedicated to eliminating adult illiteracy in New Jersey through individualized instruction and tutoring.

Nick was a two-time summer associate at Lowenstein Sandler. His prior experience includes working as a senior consultant for Appraisal Economics, an international business valuation company. In this role, he developed complex financial models; analyzed market transactions; managed valuation engagements for Fortune 500 companies; and valued complex securities, derivatives, stock options, and intangible assets.

Representative Engagements

Representing Pamplona Capital Management in connection with Bass Pro Shops’ acquisition of Cabela’s Inc. (NYSE:CAB).
Represented The Estée Lauder Companies Inc. in its $1.45 billion acquisition of Too Faced, one of the fastest growing makeup brands in the specialty-multi and online categories.
Represented Cranford Pharmaceuticals LLC in the sale of Inderal LA and Propranolol ER to ANI Pharmaceuticals Inc.
View More...

Press Mentions

Lowenstein Sandler represented Matawan Pharmaceuticals LLC in the sale of Retin-A® (tretinoin) to Perrigo Company plc (“Perrigo”) (NYSE: PRGO; TASE). Generic and brand sales of Retin-A®, a topical treatment for acne vulgaris, were valued at approximately $290 million for the 12-month period ending November 2015. The Lowenstein deal team was led by Michael Lerner and included Nick Mehler, Sam KhanNick Samedi and Robert Bee. , January 25, 2016
Lowenstein Sandler represented Metalico, Inc. (NYSE MKT: MEA), one of the nation’s largest scrap metal recyclers, in its execution of the merger agreement for the $102 million all-cash sale to Total Merchant Limited, an investment vehicle formed to seek appropriate opportunities in the United States metals and commodities market. The Lowenstein deal team included Steven M. Skolnick, Alan Wovsaniker, Sam E. KhanNick Samedi and Brian Shemesh. , September 11, 2015
Lowenstein Sandler represented Gracenote, Tribune Media Company’s (NYSE:TRCO) entertainment data division, in connection with its acquisition of SportsDirect, Inc. and Covers Media Group and the launch of Gracenote Sports. The acquisition makes Gracenote the first global provider of music, video and sports data, and enables the company to provide one-stop data solutions for its roster of blue-chip clients in the U.S. and around the world. The transaction was announced on May 28, 2015. The Lowenstein deal team was led by Christopher C. HenryJonathan D. Goodman and Nick Samedi. , May 28, 2015
View More...

Related Areas

Capital Markets & Securities
Mergers & Acquisitions
Private Equity
Transactions & Advisory Group


Georgetown University Law Center ( J.D. , 2013 )
Rutgers, The State University of New Jersey ( B.S. , 2006 ) , Finance

Bar Admissions

New York
New Jersey